Addex Therapeutics (ADXN)

• Market cap: $9.33M
• 1 day: 0.00%
• 5 days: -0.50%
• 1 month: -7.82%
• 3 months: 4.36%
• 6 months: -1.86%
• Year to date: 4.77%
• 1 year: 3.13%
• 5 years: -97.18%
• 10 years: -97.28%
• Sector: Healthcare
• Industry: Biotechnology

About: Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.

Employees: 2

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

0.02% more ownership

Funds ownership: 0.01% [Q1] → 0.02% (+0.02%) [Q2]

0% more funds holding

Funds holding: 5 [Q1] → 5 (+0) [Q2]

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

96% less capital invested

Capital invested by funds: $96.2K [Q1] → $3.46K (-$92.8K) [Q2]

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1